Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Abstract Session

Sjögren’s Disease
General Topic: Clinical Science

27M33: Abstracts: Sjögren’s Disease – Basic & Clinical Science (1680–1685)

Monday, October 27, 2025
1:00 PM - 2:30 PM Central Time
Location: S103
CE: 0.00

Non-CME In Person On Demand

    Abstract Moderator(s)

  • CB

    Chiara Baldini, MD, PhD

    University of Pisa
    Pisa, Pisa, Italy

    Disclosure(s): aurina: Advisor or Review Panel Member (Terminated); GlaxoSmithKlein(GSK): Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Horizon AMGEN: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); johnson and johnson: Advisor or Review Panel Member (Terminated, September 28, 2025); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); sanofi: Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

  • Alan Baer, MD, FACP, MACR

    Johns Hopkins University School of Medicine
    Baltimore, MD, United States

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

  • 1:00 PM - 1:15 PM Central Time
    Major salivary gland ultrasonographic features of lymphoma and high lymphoproliferative risk lesions in Sjögren’s Disease: a systematic review

    Presenting Author: Valeria Manfrè, MD – Division of Rheumatology, Department of Medicine, University of Udine, Italy; Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, WI

  • 1:15 PM - 1:30 PM Central Time
    Lymphoma and Other Malignancies in Sjögren’s Disease: Incidence, Predictive Factors, and Mortality Outcomes.

    Presenting Author: Olga Rusinovich Lovgach, MD – Puerta de Hierro University Hospital

  • 1:30 PM - 1:45 PM Central Time
    Sjögren’s Disease Salivary Gland Fibroblast Subsets are Proinflammatory and Aberrantly Promote Pain

    Presenting Author: Sara McCoy, MD;PhD;RhMSUS – University of Wisconsin

  • 1:45 PM - 2:00 PM Central Time
    Serum APRIL Is Associated With B-Cell Activation Markers, Disease Activity, and Lymphoma Risk in Sjögren Disease (SD): Data From the prospective ASSESS Cohort

    Presenting Author: Pierre-Marie Duret, MD, MSc (he/him/his) – Colmar General Hospital; Strasbourg University Hospital

  • 2:00 PM - 2:15 PM Central Time
    Integration of Multiple Spatial Transcriptomics Reveals Novel Insights into Sjogren Disease Salivary Gland Fibroblast by Peripheral Serostatus

    Presenting Author: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin

  • 2:15 PM - 2:30 PM Central Time
    The Sjögren’s Tool for Assessing Response (STAR) demonstrates its ability to accurately detect treatment efficacy in 11 recent RCTs in Sjögren’s disease

    Presenting Author: raphaele seror, MD,PhD – university hospital Paris Saclay